These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Heparin decreases the rate of proliferation of rat vascular smooth muscle cells by releasing transforming growth factor beta-like activity from serum. Grainger DJ, Witchell CM, Watson JV, Metcalfe JC, Weissberg PL. Cardiovasc Res; 1993 Dec; 27(12):2238-47. PubMed ID: 8313434 [Abstract] [Full Text] [Related]
29. Troglitazone inhibits growth and improves insulin signaling by suppression of angiotensin II action in vascular smooth muscle cells from spontaneously hypertensive rats. Fukuda N, Hu WY, Teng J, Chikara S, Nakayama M, Kishioka H, Kanmatsuse K. Atherosclerosis; 2002 Aug; 163(2):229-39. PubMed ID: 12052469 [Abstract] [Full Text] [Related]
31. Inhibition of serum and transforming growth factor beta (TGF-beta1)-induced DNA synthesis in confluent airway smooth muscle by heparin. Okona-Mensah KB, Shittu E, Page C, Costello J, Kilfeather SA. Br J Pharmacol; 1998 Oct; 125(4):599-606. PubMed ID: 9831891 [Abstract] [Full Text] [Related]
32. Abnormal regulation of transforming growth factor-beta receptors on vascular smooth muscle cells from spontaneously hypertensive rats by angiotensin II. Fukuda N, Hu WY, Kubo A, Endoh M, Kishioka H, Satoh C, Soma M, Izumi Y, Kanmatsuse K. Hypertension; 1998 Feb; 31(2):672-7. PubMed ID: 9461239 [Abstract] [Full Text] [Related]